US2023181904A1PendingUtilityA1
Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
Est. expiryApr 22, 2029(~2.7 yrs left)· nominal 20-yr term from priority
Inventors:Konstantinos AlatarisAndre B. WalkerJon ParkerYougandh ChitreSangsoo Wesley ParkJames R. Thacker
A61N 1/36075A61N 1/36157A61N 1/37235A61N 1/36021A61N 1/0553A61N 1/36171A61N 1/3787A61N 1/3616A61N 1/37264A61N 1/37241A61N 1/323A61N 1/3605A61N 1/0551A61N 1/36071A61N 1/36164A61N 1/36062A61N 1/36178A61N 1/36182A61N 1/37247A61N 1/06A61N 1/36167A61N 1/36132A61N 1/36128A61N 1/36175A61N 1/36089G01R 21/133A61N 1/326
88
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Selective high-frequency spinal chord modulation for inhibiting pain with reduced side affects and associated systems and methods are disclosed. In particular embodiments, high-frequency modulation in the range of from about 1.5 KHz to about 50 KHz may be applied to the patient's spinal chord region to address low back pain without creating unwanted sensory and/or motor side affects. In other embodiments, modulation in accordance with similar parameters can be applied to other spinal or peripheral locations to address other indications.
Claims
exact text as granted — not AI-modified1 - 137 . (canceled)
138 . A method for treating a patient, comprising:
programming a signal generator to deliver an electrical signal to the patient's dorsal horn and/or dorsal column via at least one implantable signal delivery device; and wherein the electrical signal has sequential bi-phasic pulses with a pulse width in a pulse width range from 10 microseconds to 333 microseconds and does not create paresthesia in the patient.
139 . The method of claim 138 wherein the pulses form a bi-phasic square wave.
140 . The method of claim 138 wherein the pulse width range is from 25 microseconds to 166 microseconds.
141 . The method of claim 138 wherein the pulse width range is from 33 microseconds to 100 microseconds.
142 . The method of claim 138 wherein the pulse width range is from 30 microseconds to 35 microseconds.
143 . The method of claim 138 wherein at least a portion of the electrical signal has a current amplitude in a range from 0.5 mA to 10 mA.
144 . The method of claim 138 wherein at least a portion of the electrical signal has a current amplitude in a range from 0.5 mA to 4 mA.
145 . The method of claim 138 wherein the signal generator is implantable in the patient.
146 . The method of claim 138 wherein the signal generator is external to the patient.
147 . The method of claim 138 wherein programming includes programming the signal generator to deliver the electrical signal to the patient's dorsal horn.
148 . The method of claim 138 wherein programming includes programming the signal generator to deliver the electrical signal to the patient's dorsal column.
149 . The method of claim 138 wherein programming includes programming the signal generator to deliver the electrical signal to the patient's epidural space.
150 . The method of claim 138 wherein programming includes programming the signal generator to deliver the electrical signal to reduce patient pain.
151 . A method for treating a patient, comprising:
programming a signal generator to deliver an electrical signal to the patient's dorsal horn and/or dorsal column via at least one implantable signal delivery device; and wherein the electrical signal has sequential bi-phasic pulses having a pulse width in a pulse width range from 10 microseconds to 333 microseconds and an amplitude that does not create paresthesia in the patient.
152 . The method of claim 151 wherein the pulses form a bi-phasic square wave.
153 . The method of claim 151 wherein the pulse width range is from 30 microseconds to 35 microseconds.
154 . The method of claim 151 wherein at least a portion of the electrical signal has a current amplitude in a range from 0.5 mA to 10 mA.
155 . The method of claim 151 wherein at least a portion of the electrical signal has a current amplitude in a range from 0.5 mA to 4 mA.
156 . The method of claim 151 wherein the signal generator is implantable in the patient.
157 . The method of claim 151 wherein the signal generator is external to the patient.
158 . The method of claim 151 wherein programming includes programming the signal generator to deliver the electrical signal to the patient's dorsal horn.
159 . The method of claim 151 wherein programming includes programming the signal generator to deliver the electrical signal to the patient's dorsal column.
160 . The method of claim 151 wherein programming includes programming the signal generator to deliver the electrical signal to reduce or eliminate patient pain.
161 . A method for treating a patient, comprising:
delivering an electrical signal to the patient's dorsal horn and/or dorsal column via at least one implantable signal delivery device; and wherein the electrical signal has sequential bi-phasic pulses with a pulse width in a pulse width range from 10 microseconds to 333 microseconds and does not create paresthesia in the patient.
162 . The method of claim 161 wherein delivering the electrical signal includes delivering the electrical signal to a vertebral location within a range from T9-T12.
163 . The method of claim 161 wherein delivering the electrical signal includes delivering the electrical signal to a vertebral location within a range from T9-T10.Join the waitlist — get patent alerts
Track US2023181904A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.